Dominique L. P. Baeten
#164,145
Most Influential Person Now
Dominique L. P. Baeten's AcademicInfluence.com Rankings
Dominique L. P. Baetenphilosophy Degrees
Philosophy
#9585
World Rank
#13167
Historical Rank
Logic
#6557
World Rank
#8084
Historical Rank
Dominique L. P. Baetenbiology Degrees
Biology
#13195
World Rank
#16727
Historical Rank
Immunology
#902
World Rank
#925
Historical Rank
Download Badge
Philosophy Biology
Dominique L. P. Baeten's Degrees
- PhD Immunology University of Amsterdam
- Doctorate Medicine University of Amsterdam
Why Is Dominique L. P. Baeten Influential?
(Suggest an Edit or Addition)Dominique L. P. Baeten's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis. (2015) (728)
- Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial (2013) (513)
- Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis (2004) (427)
- Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathy. (2002) (362)
- Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance (2007) (353)
- Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice. (2006) (314)
- Arthritis 2 Spondyloarthritis (2011) (313)
- Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor α (infliximab) in spondyloarthropathy: an open pilot study (2000) (311)
- Interleukin-17-positive mast cells contribute to synovial inflammation in spondylarthritis. (2012) (267)
- Synovial histopathology of psoriatic arthritis, both oligo- and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis (2005) (264)
- A randomized controlled trial with an anti-CCL2 (anti-monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritis. (2006) (250)
- Comparative study of the synovial histology in rheumatoid arthritis, spondyloarthropathy, and osteoarthritis: influence of disease duration and activity (2000) (248)
- Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study (2018) (237)
- Modulation of CCR2 in rheumatoid arthritis: a double-blind, randomized, placebo-controlled clinical trial. (2008) (218)
- Effect of secukinumab on clinical and radiographic outcomes in ankylosing spondylitis: 2-year results from the randomised phase III MEASURE 1 study (2016) (212)
- Ankylosing spondylitis and bowel disease. (2002) (206)
- Spondyloarthritis (2011) (205)
- Immunomodulatory effects of anti-tumor necrosis factor alpha therapy on synovium in spondylarthropathy: histologic findings in eight patients from an open-label pilot study. (2001) (193)
- Macrophages expressing the scavenger receptor CD163: a link between immune alterations of the gut and synovial inflammation in spondyloarthropathy (2001) (182)
- Prevalence of peripheral and extra-articular disease in ankylosing spondylitis versus non-radiographic axial spondyloarthritis: a meta-analysis (2016) (173)
- Infliximab, but not etanercept, induces IgM anti-double-stranded DNA autoantibodies as main antinuclear reactivity: biologic and clinical implications in autoimmune arthritis. (2005) (165)
- Absence of a classically activated macrophage cytokine signature in peripheral spondylarthritis, including psoriatic arthritis. (2009) (159)
- Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation (2017) (157)
- Involvement of matrix metalloproteinases and their inhibitors in peripheral synovitis and down-regulation by tumor necrosis factor alpha blockade in spondylarthropathy. (2004) (153)
- Magnetic Resonance Imaging of the Sacroiliac Joints Indicating Sacroiliitis According to the Assessment of SpondyloArthritis international Society Definition in Healthy Individuals, Runners, and Women With Postpartum Back Pain (2018) (151)
- Infiltration of the synovial membrane with macrophage subsets and polymorphonuclear cells reflects global disease activity in spondyloarthropathy (2005) (150)
- Synovial intracellular citrullinated proteins colocalizing with peptidyl arginine deiminase as pathophysiologically relevant antigenic determinants of rheumatoid arthritis-specific humoral autoimmunity. (2005) (140)
- Fibrin Deimination in Synovial Tissue Is Not Specific for Rheumatoid Arthritis but Commonly Occurs during Synovitides1 (2005) (138)
- Association of CD163+ macrophages and local production of soluble CD163 with decreased lymphocyte activation in spondylarthropathy synovitis. (2004) (138)
- Regulation of IFN response gene activity during infliximab treatment in rheumatoid arthritis is associated with clinical response to treatment (2010) (137)
- The novel cytokine interleukin-36α is expressed in psoriatic and rheumatoid arthritis synovium (2012) (136)
- Ectopic lymphoid neogenesis in psoriatic arthritis (2007) (135)
- Synovial lymphoid neogenesis does not define a specific clinical rheumatoid arthritis phenotype. (2008) (130)
- Specific presence of intracellular citrullinated proteins in rheumatoid arthritis synovium: Relevance to antifilaggrin autoantibodies (2001) (130)
- Fc gamma receptor-TLR cross-talk elicits pro-inflammatory cytokine production by human M2 macrophages (2014) (127)
- Intimal lining layer macrophages but not synovial sublining macrophages display an IL-10 polarized-like phenotype in chronic synovitis (2012) (125)
- The IL-17A-producing CD8+ T-cell population in psoriatic lesional skin comprises mucosa-associated invariant T cells and conventional T cells. (2014) (124)
- Tumor necrosis factor alpha blockade treatment down-modulates the increased systemic and local expression of Toll-like receptor 2 and Toll-like receptor 4 in spondylarthropathy. (2005) (124)
- Emerging role of IL-17 and Th17 cells in systemic lupus erythematosus. (2014) (123)
- Differential expression and response to anti‐TNFα treatment of infiltrating versus resident tissue macrophage subsets in autoimmune arthritis (2005) (121)
- B Lymphocyte Autoimmunity in Rheumatoid Synovitis Is Independent of Ectopic Lymphoid Neogenesis1 (2008) (121)
- Inflamed target tissue provides a specific niche for highly expanded T-cell clones in early human autoimmune disease (2012) (119)
- Pathogenesis of spondyloarthritis: autoimmune or autoinflammatory? (2012) (113)
- Are spondylarthritides related but distinct conditions or a single disease with a heterogeneous phenotype? (2013) (113)
- Inflammatory pathways in spondyloarthritis. (2014) (110)
- Control of Cytokine Production by Human Fc Gamma Receptors: Implications for Pathogen Defense and Autoimmunity (2015) (108)
- Phenotypically and functionally distinct CD8+ lymphocyte populations in long-term drug-free tolerance and chronic rejection in human kidney graft recipients. (2005) (103)
- Tumour necrosis factor blockade increases lymphangiogenesis in murine and human arthritic joints (2008) (102)
- Histone deacetylase 3 regulates the inflammatory gene expression programme of rheumatoid arthritis fibroblast-like synoviocytes (2016) (102)
- Axial spondyloarthritis (2015) (102)
- A 588-gene microarray analysis of the peripheral blood mononuclear cells of spondyloarthropathy patients. (2002) (102)
- Impaired Th1 cytokine production in spondyloarthropathy is restored by anti-TNFα (2001) (100)
- Circulating miRNA-125b Is a Potential Biomarker Predicting Response to Rituximab in Rheumatoid Arthritis (2014) (99)
- Diagnostic classification of spondylarthropathy and rheumatoid arthritis by synovial histopathology: a prospective study in 154 consecutive patients. (2004) (97)
- The relationship between synovial lymphocyte aggregates and the clinical response to infliximab in rheumatoid arthritis: a prospective study. (2009) (94)
- Immunomodulatory effects of etanercept on peripheral joint synovitis in the spondylarthropathies. (2005) (94)
- Anti-TNF treatment blocks the induction of T cell-dependent humoral responses (2012) (93)
- Type I IFN and TNFα cross-regulation in immune-mediated inflammatory disease: basic concepts and clinical relevance (2010) (93)
- TNF-α blockade induces IL-10 expression in human CD4+ T cells (2014) (90)
- Distinct serum and synovial fluid interleukin (IL)-33 levels in rheumatoid arthritis, psoriatic arthritis and osteoarthritis. (2012) (87)
- The interleukin-23/interleukin-17 immune axis as a promising new target in the treatment of spondyloarthritis (2014) (86)
- Nerve growth factor and receptor expression in rheumatoid arthritis and spondyloarthritis (2009) (85)
- The abundant synovial expression of the RANK/RANKL/Osteoprotegerin system in peripheral spondylarthritis is partially disconnected from inflammation. (2008) (85)
- Clues to pathogenesis of spondyloarthropathy derived from synovial fluid mononuclear cell gene expression profiles. (2002) (85)
- Alterations of the synovial T cell repertoire in anti-citrullinated protein antibody-positive rheumatoid arthritis. (2009) (84)
- Identification of synovial biomarkers of response to experimental treatment in early-phase clinical trials in spondylarthritis. (2006) (83)
- The inflammatory function of human IgA (2018) (82)
- Serum levels of matrix metalloproteinase 3 and macrophage colony-stimulating factor 1 correlate with disease activity in ankylosing spondylitis. (2004) (82)
- Calprotectin serum level is an independent marker for radiographic spinal progression in axial spondyloarthritis (2014) (81)
- Immunosuppressive drug‐free operational immune tolerance in human kidney transplant recipients: Part I. blood gene expression statistical analysis (2008) (79)
- Risk factors for flare and treatment of disease flares during pregnancy in rheumatoid arthritis and axial spondyloarthritis patients (2017) (78)
- Gut inflammation and spondyloarthropathies (2002) (75)
- Identification and characterisation of citrullinated antigen-specific B cells in peripheral blood of patients with rheumatoid arthritis (2015) (75)
- Genetic studies on components of the Wnt signalling pathway and the severity of joint destruction in rheumatoid arthritis (2012) (75)
- How Cytokine Networks Fuel Inflammation: Interleukin-17 and a tale of two autoimmune diseases (2013) (73)
- Dual neutralisation of interleukin-17A and interleukin-17F with bimekizumab in patients with active ankylosing spondylitis: results from a 48-week phase IIb, randomised, double-blind, placebo-controlled, dose-ranging study (2020) (73)
- Interleukin‐9 Overexpression and Th9 Polarization Characterize the Inflamed Gut, the Synovial Tissue, and the Peripheral Blood of Patients With Psoriatic Arthritis (2016) (71)
- Calprotectin (S100A8/9) as serum biomarker for clinical response in proof-of-concept trials in axial and peripheral spondyloarthritis (2014) (71)
- Citrullinated proteins in rheumatoid arthritis: crucial...but not sufficient! (2006) (71)
- Detection of major histocompatibility complex/human cartilage gp-39 complexes in rheumatoid arthritis synovitis as a specific and independent histologic marker. (2004) (70)
- Long-term effects of secukinumab on MRI findings in relation to clinical efficacy in subjects with active ankylosing spondylitis: an observational study (2015) (68)
- Interleukin‐17A Inhibition Diminishes Inflammation and New Bone Formation in Experimental Spondyloarthritis (2019) (68)
- B Cell Clonal Expansion and Somatic Hypermutation of Ig Variable Heavy Chain Genes in the Synovial Membrane of Patients with Osteoarthritis1 (2007) (66)
- The value of rheumatoid factor and anti-citrullinated protein antibodies as predictors of response to infliximab in rheumatoid arthritis: an exploratory study. (2011) (66)
- Effect of Secukinumab on Patient‐Reported Outcomes in Patients With Active Ankylosing Spondylitis: A Phase III Randomized Trial (MEASURE 1) (2016) (64)
- Human mast cells capture, store, and release bioactive, exogenous IL‐17A (2016) (64)
- Inflammatory cytokines epigenetically regulate rheumatoid arthritis fibroblast-like synoviocyte activation by suppressing HDAC5 expression (2014) (62)
- Efficacy and safety of adalimumab for the treatment of peripheral arthritis in spondyloarthritis patients without ankylosing spondylitis or psoriatic arthritis (2012) (62)
- Localization of MHC Class II/Human Cartilage Glycoprotein-39 Complexes in Synovia of Rheumatoid Arthritis Patients Using Complex-Specific Monoclonal Antibodies (2003) (61)
- Distinct synovial immunopathology in Behçet disease and psoriatic arthritis (2009) (60)
- The role of B lymphocytes in the progression from autoimmunity to autoimmune disease. (2013) (59)
- The Initiation, but Not the Persistence, of Experimental Spondyloarthritis Is Dependent on Interleukin-23 Signaling (2018) (58)
- Disease-specific and inflammation-independent stromal alterations in spondylarthritis synovitis. (2013) (57)
- Relationship between inflammation, bone destruction, and osteoproliferation in the HLA-B27/human β2 -microglobulin-transgenic rat model of spondylarthritis. (2012) (57)
- A proliferation inducing ligand (APRIL) promotes IL-10 production and regulatory functions of human B cells. (2016) (56)
- Myeloid‐Related Proteins 8 and 14 Contribute to Monosodium Urate Monohydrate Crystal–Induced Inflammation in Gout (2014) (55)
- Tumor necrosis factor alpha drives cadherin 11 expression in rheumatoid inflammation. (2008) (55)
- Group 2 Innate Lymphoid Cells Attenuate Inflammatory Arthritis and Protect from Bone Destruction in Mice. (2018) (54)
- Ankylosing spondylitis and bowel disease. (2006) (53)
- Differences in pathophysiology between rheumatoid arthritis and ankylosing spondylitis. (2009) (53)
- Brief Report: Tumor Necrosis Factor and Interleukin‐6 Differentially Regulate Dkk‐1 in the Inflamed Arthritic Joint (2015) (52)
- Citrullination of Epithelial Neutrophil–Activating Peptide 78/CXCL5 Results in Conversion From a Non–Monocyte‐Recruiting Chemokine to a Monocyte‐Recruiting Chemokine (2014) (50)
- Increased cortisol relative to adrenocorticotropic hormone predicts improvement during anti-tumor necrosis factor therapy in rheumatoid arthritis. (2008) (50)
- APRIL Induces a Novel Subset of IgA+ Regulatory B Cells That Suppress Inflammation via Expression of IL-10 and PD-L1 (2019) (50)
- Ectopic lymphoid neogenesis is strongly associated with activation of the IL-23 pathway in rheumatoid synovitis (2015) (50)
- Soluble Immune Complexes Shift the TLR-Induced Cytokine Production of Distinct Polarized Human Macrophage Subsets towards IL-10 (2012) (49)
- Analysis of apoptosis in peripheral blood and synovial tissue very early after initiation of infliximab treatment in rheumatoid arthritis patients. (2008) (48)
- Ideal target for psoriatic arthritis? Comparison of remission and low disease activity states in a real-life cohort (2017) (46)
- Soluble Biomarkers of Cartilage and Bone Metabolism in Early Proof of Concept Trials in Psoriatic Arthritis: Effects of Adalimumab Versus Placebo (2010) (46)
- Serum IgA Immune Complexes Promote Proinflammatory Cytokine Production by Human Macrophages, Monocytes, and Kupffer Cells through FcαRI–TLR Cross-Talk (2017) (44)
- Type I interferons have no major influence on humoral autoimmunity in rheumatoid arthritis. (2010) (43)
- Angiopoietin-2 promotes inflammatory activation of human macrophages and is essential for murine experimental arthritis (2012) (43)
- Serum inflammatory biomarkers fail to identify early axial spondyloarthritis: results from the SpondyloArthritis Caught Early (SPACE) cohort (2017) (43)
- Tie2 Signaling Cooperates with TNF to Promote the Pro-Inflammatory Activation of Human Macrophages Independently of Macrophage Functional Phenotype (2014) (43)
- Identification of interleukin-7 as a candidate disease mediator in spondylarthritis. (2008) (43)
- Spondyloarthritis: from unifying concepts to improved treatment. (2014) (42)
- Distinct synovial immunopathologic characteristics of juvenile-onset spondylarthritis and other forms of juvenile idiopathic arthritis. (2006) (41)
- Immunopathology of synovitis: from histology to molecular pathways. (2016) (40)
- Chemical agents and enzymes used for the extraction of gut lymphocytes influence flow cytometric detection of T cell surface markers. (2000) (39)
- Review: Animal Models as a Tool to Dissect Pivotal Pathways Driving Spondyloarthritis (2015) (39)
- Standardisation of synovial tissue infiltrate analysis: how far have we come? how much further do we need to go? (2005) (39)
- Peripheral joint inflammation in early onset spondyloarthritis is not specifically related to enthesitis (2013) (39)
- Variable domain N‐linked glycosylation and negative surface charge are key features of monoclonal ACPA: Implications for B‐cell selection (2018) (38)
- Persistently activated, proliferative memory autoreactive B cells promote inflammation in rheumatoid arthritis (2020) (38)
- Biologics for rare inflammatory diseases: TNF blockade in the SA PHO syndrome. (2012) (38)
- Presence and role of anti-citrullinated protein antibodies in experimental arthritis models. (2013) (37)
- Gut inflammation in the spondyloarthropathies (2005) (36)
- Interleukin 6/Wnt interactions in rheumatoid arthritis: interleukin 6 inhibits Wnt signaling in synovial fibroblasts and osteoblasts (2016) (36)
- Increased numbers of CD5+ B lymphocytes with a regulatory phenotype in spondylarthritis. (2012) (35)
- Spondylarthritis in the absence of B lymphocytes. (2008) (35)
- FcαRI co-stimulation converts human intestinal CD103+ dendritic cells into pro-inflammatory cells through glycolytic reprogramming (2018) (35)
- Brief Report: Interleukin‐17 Blockade With Secukinumab in Peripheral Spondyloarthritis Impacts Synovial Immunopathology Without Compromising Systemic Immune Responses (2018) (34)
- Adalimumab serum levels and antidrug antibodies towards adalimumab in peripheral spondyloarthritis: no association with clinical response to treatment or with disease relapse upon treatment discontinuation (2014) (34)
- Anti-CD74 antibodies have no diagnostic value in early axial spondyloarthritis: data from the spondyloarthritis caught early (SPACE) cohort (2018) (34)
- Proinflammatory CX3CR1+CD59+Tumor Necrosis Factor–Like Molecule 1A+Interleukin‐23+ Monocytes Are Expanded in Patients With Ankylosing Spondylitis and Modulate Innate Lymphoid Cell 3 Immune Functions (2018) (33)
- Technical validation of cDNA based microarray as screening technique to identify candidate genes in synovial tissue biopsy specimens from patients with spondyloarthropathy (2004) (33)
- Bone formation in ankylosing spondylitis during anti-tumour necrosis factor therapy imaged by 18F-fluoride positron emission tomography (2018) (32)
- Undifferentiated spondyloarthritis vs ankylosing spondylitis and psoriatic arthritis: a real-life prospective cohort study of clinical presentation and response to treatment. (2013) (31)
- Exposure to nuclear antigens contributes to the induction of humoral autoimmunity during tumour necrosis factor alpha blockade (2008) (30)
- Immune linkages between inflammatory bowel disease and spondyloarthropathies. (2002) (30)
- Efficacy and Safety of Bimekizumab in Moderate to Severe Hidradenitis Suppurativa (2021) (30)
- Expression of host defense scavenger receptors in spondylarthropathy. (2001) (29)
- Achieving remission in psoriatic arthritis by early initiation of TNF inhibition: a double-blind, randomised, placebo-controlled trial of golimumab plus methotrexate versus placebo plus methotrexate (2019) (29)
- Synovial tissue analysis in clinical trials. (2005) (29)
- Expansion of Interleukin‐22– and Granulocyte–Macrophage Colony‐Stimulating Factor–Expressing, but Not Interleukin‐17A–Expressing, Group 3 Innate Lymphoid Cells in the Inflamed Joints of Patients With Spondyloarthritis (2019) (29)
- Increased arterial wall inflammation in patients with ankylosing spondylitis is reduced by statin therapy (2016) (27)
- IL-17 in spondyloarthritis: is the T-party over? (2011) (27)
- Peripheral disease contributes significantly to the level of disease activity in axial spondyloarthritis (2019) (26)
- Efficacy and safety of secukinumab in Asian patients with active ankylosing spondylitis: 52‐week pooled results from two phase 3 studies (2017) (25)
- Endoplasmic reticulum stress cooperates with Toll-like receptor ligation in driving activation of rheumatoid arthritis fibroblast-like synoviocytes (2017) (25)
- The acetyl code in rheumatoid arthritis and other rheumatic diseases. (2017) (25)
- C-Reactive Protein Promotes Inflammation through FcγR-Induced Glycolytic Reprogramming of Human Macrophages (2019) (24)
- Efficacy and safety of bimekizumab as add-on therapy for rheumatoid arthritis in patients with inadequate response to certolizumab pegol: a proof-of-concept study (2019) (24)
- A proliferation‐inducing ligand–mediated anti‐inflammatory response of astrocytes in multiple sclerosis (2019) (24)
- Gut mucosal T cell lines from ankylosing spondylitis patients are enriched with alphaEbeta7 integrin. (2001) (24)
- FcγR-TLR Cross-Talk Enhances TNF Production by Human Monocyte-Derived DCs via IRF5-Dependent Gene Transcription and Glycolytic Reprogramming (2019) (23)
- Generation and Characterization of Anti–Citrullinated Protein Antibody–Producing B Cell Clones From Rheumatoid Arthritis Patients (2019) (23)
- Interleukin (IL)-12 and IL-18 Synergize to Promote MAIT Cell IL-17A and IL-17F Production Independently of IL-23 Signaling (2020) (23)
- Prediction of diagnosis in patients with early arthritis using a combined Kohonen mapping and instance-based evaluation criterion (2004) (22)
- The TNF family member APRIL dampens collagen-induced arthritis (2012) (22)
- Non-conventional forms of HLA-B27 are expressed in spondyloarthritis joints and gut tissue (2016) (22)
- Infliximab in patients who have spondyloarthropathy: clinical efficacy, safety, and biological immunomodulation. (2003) (22)
- A comparative phenotypical analysis of rheumatoid nodules and rheumatoid synovium with special reference to adhesion molecules and activation markers (1998) (22)
- Increased systemic and local expression of toll-like receptor 2 and 4 in spondyloarthropathy is downmodulated by tumour necrosis factor alpha blockade (2005) (22)
- Interleukin-23: a central cytokine in the pathogenesis of spondylarthritis. (2011) (22)
- Mechanisms and clinical relevance of TRAIL-triggered responses in the synovial fibroblasts of patients with rheumatoid arthritis. (2011) (22)
- Class 3 semaphorins modulate the invasive capacity of rheumatoid arthritis fibroblast-like synoviocytes (2018) (21)
- Melanoma inhibitory activity, a biomarker related to chondrocyte anabolism, is reversibly suppressed by proinflammatory cytokines in rheumatoid arthritis (2008) (21)
- Transmembrane TNF drives osteoproliferative joint inflammation reminiscent of human spondyloarthritis (2020) (21)
- Dual neutralisation of IL-17F and IL-17A with bimekizumab blocks inflammation-driven osteogenic differentiation of human periosteal cells (2020) (21)
- Control of cytokine mRNA degradation by the histone deacetylase inhibitor ITF2357 in rheumatoid arthritis fibroblast-like synoviocytes: beyond transcriptional regulation (2018) (21)
- Interleukin-17A Blockade with Secukinumab Reduces Spinal Inflammation in Patients with Ankylosing Spondylitis As Early As Week 6, As Detected by Magnetic Resonance Imaging (2011) (21)
- The histopathology of spondyloarthropathy. (2004) (21)
- Innate Immune Activation Can Trigger Experimental Spondyloarthritis in HLA-B27/Huβ2m Transgenic Rats (2017) (20)
- Histologic evidence that mast cells contribute to local tissue inflammation in peripheral spondyloarthritis by regulating interleukin-17A content (2018) (20)
- Fc gamma receptor IIa suppresses type I and III interferon production by human myeloid immune cells (2018) (19)
- Use of TNF blockers and other targeted therapies in rare refractory immune-mediated inflammatory diseases: evidence-based or rational? (2010) (19)
- Fast relapse upon discontinuation of tumour necrosis factor blocking therapy in patients with peripheral spondyloarthritis (2013) (19)
- A single determination of C-reactive protein does not suffice to declare a patient with a diagnosis of axial spondyloarthritis ‘CRP-negative’ (2018) (18)
- A psychometric analysis of outcome measures in peripheral spondyloarthritis (2015) (18)
- Beneficial Immune Effects of Myeloid‐Related Proteins in Kidney Transplant Rejection (2016) (18)
- Mediators of structural remodeling in peripheral spondylarthritis. (2009) (17)
- A proof-of-concept study with the tyrosine kinase inhibitor nilotinib in spondyloarthritis (2016) (17)
- 'MRI-tis' in the early diagnosis of axial SpA: issues and limitations (2010) (16)
- Clinical and Imaging Signs of Spondyloarthritis in First‐Degree Relatives of HLA–B27–Positive Ankylosing Spondylitis Patients: The Pre‐Spondyloarthritis (Pre‐SpA) Cohort Study (2016) (16)
- mTOR Blockade by Rapamycin in Spondyloarthritis: Impact on Inflammation and New Bone Formation in vitro and in vivo (2020) (16)
- In vitro spontaneous osteoclastogenesis of human peripheral blood mononuclear cells is not crucially dependent on T lymphocytes. (2009) (16)
- Peptidylarginine deiminase isoforms expressed in the synovial membrane of rheumatoid arthritis patients (2003) (16)
- Promotion of macrophage activation by Tie2 in the context of the inflamed synovia of rheumatoid arthritis and psoriatic arthritis patients (2019) (16)
- In-reactor anaerobic digestion of MSW-organics (1993) (15)
- Selective targeting of PI3Kδ suppresses human IL-17-producing T cells and innate-like lymphocytes and may be therapeutic for IL-17-mediated diseases. (2020) (15)
- Prediction of arthritis using a modified Kohonen mapping and case based reasoning (2004) (15)
- Predictive immunomonitoring -- the COST ENTIRE initiative. (2013) (15)
- LB0001 Dual neutralisation of il-17a and il-17f with bimekizumab in patients with active ankylosing spondylitis (AS): 12-week results from a phase 2b, randomised, double-blind, placebo-controlled, dose-ranging study (2018) (14)
- Anti-interleukin 6 receptor therapy for hyper-IgD syndrome (2015) (14)
- Lessons to be learned from serum biomarkers in psoriasis and IBD – the potential role in SpA (2017) (14)
- IL-12p40/IL-23p40 Blockade With Ustekinumab Decreases the Synovial Inflammatory Infiltrate Through Modulation of Multiple Signaling Pathways Including MAPK-ERK and Wnt (2021) (14)
- Enhanced costimulation by CD70+ B cells aggravates experimental autoimmune encephalomyelitis in autoimmune mice (2013) (13)
- Synovial tissue macrophages : highly sensitive biomarkers for response to treatment in rheumatoid arthritis patients (2004) (12)
- Altered cytokine expression by macrophages from HLA-B27-positive spondyloarthritis patients without evidence of endoplasmic reticulum stress (2018) (12)
- 3 Fc gamma receptor-tlr cross-talk elicits pro-inflammatory cytokine production by human m 2 macrophages (2019) (12)
- IL-23 Inhibition in Ankylosing Spondylitis: Where Did It Go Wrong? (2021) (12)
- ER stress abrogates the immunosuppressive effect of IL-10 on human macrophages through inhibition of STAT3 activation (2019) (12)
- Alpha beta but not gamma delta T cell clones in synovial fluids of patients with reactive arthritis show active transcription of tumour necrosis factor alpha and interferon gamma. (2004) (11)
- Pathogenesis of spondyloarthritis: Insights from synovial membrane studies (2006) (11)
- IgG Subclasses Shape Cytokine Responses by Human Myeloid Immune Cells through Differential Metabolic Reprogramming (2020) (11)
- Immune complexes shift the TLR-induced cytokine production of distinct polarized human macrophage subsets towards IL-10 (2011) (11)
- A functional polymorphism of TIR-domain-containing adaptor protein is not associated with axial spondyloarthritis (2007) (11)
- BOB.1 controls memory B-cell fate in the germinal center reaction. (2019) (10)
- Impact of the B Cell Growth Factor APRIL on the Qualitative and Immunological Characteristics of Atherosclerotic Plaques (2016) (10)
- Dual Blockade of TNF and IL-17A Inhibits Inflammation and Structural Damage in a Rat Model of Spondyloarthritis (2022) (10)
- Alpha beta but not gamma delta T cell clones in synovial fluids of patients with reactive arthritis show active transcription of tumour necrosis factor α and interferon γ (2004) (10)
- Structure-modifying capacity of anti-tumour necrosis factor-alpha therapy in ankylosing spondylitis. (2004) (9)
- Influence of the gut and cytokine patterns in spondyloarthropathy. (2002) (9)
- Interleukin‐17A Is Produced by CD4+ but Not CD8+ T Cells in Synovial Fluid Following T Cell Receptor Activation and Regulates Different Inflammatory Mediators Compared to Tumor Necrosis Factor in a Model of Psoriatic Arthritis Synovitis (2020) (9)
- FHL2 regulates the resolution of tissue damage in chronic inflammatory arthritis (2014) (9)
- 02.13 Il-17f contributes to human chronic inflammation in synovial tissue: Preclinical evidence with dual il-17a and il-17f inhibition with bimekizumab in psoriatic arthritis (2017) (9)
- Killer immunoglobulin receptor genes in spondyloarthritis (2016) (8)
- Residual disease activity and treatment adjustments in psoriatic arthritis in current clinical practice (2017) (8)
- IL-17A is produced by synovial fluid CD4+ but not CD8+ T cells after TCR activation and regulates different inflammatory mediators compared to TNF in a synovitis model of psoriatic arthritis. (2020) (8)
- Dynamic T cell receptor clonotype changes in synovial tissue of patients with early rheumatoid arthritis: effects of treatment with cyclosporin A (Neoral). (2002) (8)
- Structure-Modifying Capacity of Anti-Tumour Necrosis Factor-α Therapy in Ankylosing Spondylitis (2012) (8)
- Interleukin 17A and IL-17F Expression and Functional Responses in Rheumatoid Arthritis and Peripheral Spondyloarthritis (2020) (8)
- Autoimmunity and inflammation are independent of class II transactivator type PIV-dependent class II major histocompatibility complex expression in peripheral tissues during collagen-induced arthritis. (2011) (8)
- The cartilage protein melanoma inhibitory activity contributes to inflammatory arthritis. (2014) (8)
- Effect of infliximab treatment on T cell cytokine responses in spondylarthropathy: comment on the article by Zou et al. (2004) (8)
- EVALUATION OF EFFICACY AND SAFETY OF SECUKINUMAB IN THE TREATMENT OF PATIENTS WITH MODERATE-TO-SEVERE ANKYLOSING SPONDYLITIS (2012) (8)
- O015 Il-17 blockade with secukinumab in peripheral spondyloarthritis impacts synovial immunopathology without compromising systemic immune responses (2018) (8)
- THU0376 Prevalence of Peripheral and Extra-Articular Disease in Ankylosing Spondylitis versus Non-Radiographic Axial Spondyloarthritis: A Meta-Analysis (2016) (8)
- Dysregulated Fcγ receptor IIa‐induced cytokine production in dendritic cells of lupus nephritis patients (2019) (8)
- Localisation of MHC Class II/HC gp-39 complexes in synovia of rheumatoid arthritis patients using complex-specific monoclonal antibodies (2003) (8)
- TNFα Blockade Impairs T Cell Dependent Antibody Responses (2010) (7)
- Is expression of intracellular citrullinated proteins in synovial tissue specific for rheumatoid arthritis? Comment on the article by Baeten et al - Reply. (2002) (7)
- 699 Dual IL-17A and IL-17F inhibition with bimekizumab provides evidence for IL-17F contribution to immune-mediated inflammatory skin response (2017) (7)
- SAT0029 THE IMMUNE-PATHOGENIC CHARACTERISTICS OF AUTOREACTIVE B CELLS AGAINST CITRULLINATED ANTIGENS IN RHEUMATOID ARTHRITIS (2019) (7)
- TNF blockade abrogates the induction of T cell‐dependent humoral responses in an allotransplantation model (2011) (7)
- A2.15 Relative Overexpression of Transmembrane Versus Soluble TNF in Human and Experimental Spondyloarthritis (2013) (7)
- Progression From Subclinical Inflammation to Overt Spondyloarthritis in First‐Degree Relatives of Patients in Association With HLA–B27: The Pre‐Spondyloarthritis Cohort (2021) (6)
- Anti-IL-17A treatment reduces serum inflammatory, angiogenic and tissue remodeling biomarkers accompanied by less synovial high endothelial venules in peripheral spondyloarthritis (2020) (6)
- Synovial and mucosal immunopathology in spondyloarthritis. (2009) (6)
- OP0202 Anti-IL-17A Treatment Blocks Inflammation and New Bone Formation in Experimental Spondyloarthritis in HLA-B27 Transgenic Rats (2015) (6)
- New treatment paradigms in spondyloarthritis (2018) (6)
- Long Term Inhibition of Interleukin (IL)-17A with Secukinumab Improves Clinical Symptoms and Reduces Spinal Inflammation As Assessed by Magnetic Resonance Imaging in Patients with Ankylosing Spondylitis. (2012) (6)
- Sustained Rap1 activation in autoantigen-specific T lymphocytes attenuates experimental autoimmune encephalomyelitis (2012) (5)
- Altered BANK1 expression is not associated with humoral autoimmunity in chronic joint inflammation. (2013) (5)
- Synovial Tissue Response to Treatment with TNF Blockers in Peripheral Spondyloarthritis (2011) (5)
- Increased number of macrophages in non-inflamed colon of patients with spondyloarthropathy, a human model of early Crohn's disease (2000) (5)
- Bone formation in ankylosing spondylitis during anti-tumour necrosis factor therapy imaged by 18F-fluoride positron emission tomography (2018) (5)
- Gut mucosal T cell lines from ankylosing spondylitis patients are enriched with E 7 integrin (2002) (5)
- The presence of deiminated fibrin in the synovial membrane is not specific for rheumatoid arthritis (2004) (5)
- 9 The IL-23 / IL-17 immune axis as a promising new target in the treatment of spondyloarthritis (2014) (5)
- FRI0420 Long term inhibition of IL-17a with secukinumab reduces spinal inflammation but has no influence on fatty lesions as assessed by magnetic resonance imaging in patients with ankylosing spondylitis (2013) (5)
- IgM anti-dsDNA autoantibodies are the main antinuclear reactivity induced by infliximab but not etanercept treatment in vivo: Biological and clinical implications (2005) (5)
- OP0297 Calprotectin (S100A8/9) as Serum Biomarker for Clinical Response in Proof-Of-Concept Trials in Axial and Peripheral Spondyloarthritis (2014) (4)
- Autoimmunity: break-through in the diagnosis and treatment of immune-mediated inflammatory diseases. (2014) (4)
- T cell cytokines in gut mucosa of patients with spondyloarthropathy reflect immune alterations in Crohn's disease (1999) (4)
- C-Reactive Protein Controls IL-23 Production by Human Monocytes (2021) (4)
- Recent Advances in the Treatment of Immune-Mediated Inflammatory Diseases. (2016) (4)
- Long-term efficacy and predictors of remission following adalimumab treatment in peripheral spondyloarthritis: 3-year results from ABILITY-2 (2018) (4)
- Manure and municipal solid waste fermentation in flanders: An appraisal (1988) (4)
- A Positive MRI of the Sacroiliac Joints Is Not Specific for Axial Spondyloarthritis but Frequently Occurs in Healthy Individuals (2017) (4)
- Identification of robust and disease-specific stromal alterations in spondyloarthritis synovitis (2011) (3)
- Immune-mediated inflammatory diseases: a new multidisciplinary concept. (2009) (3)
- Infliximab: a chimeric anti-TNF-α monoclonal antibody for the treatment of ankylosing spondylitis and other spondyloarthritides (2006) (3)
- First-degree relatives of axial spondyloarthritis patients of the pre-SpA cohort would consider using medication in a preventive setting (2018) (3)
- Relationship between inflammation, bone destruction, and osteoproliferation in spondyloarthritis in HLA-B27/Hu β 2m transgenic rats (2012) (3)
- Intestinal mucosa of patients with spondyloarthropathy is enriched with T cells carrying alpha E beta 7 integrin, even in the absence of histologically defined inflammation (1999) (3)
- Transcriptional regulator BOB.1: Molecular mechanisms and emerging role in chronic inflammation and autoimmunity. (2021) (3)
- FRI0460 Differences and similarities of spondyloarthritis classification subgroups defined by the assessment of spondyloarthritis international society (ASAS) (2013) (3)
- SAT0337 Clinical Response and Remission in Patients with Non-Radiographic Axial Spondyloarthritis after Three Years of Adalimumab Therapy (2014) (3)
- TNF and IL-6 differentially regulate the production of DKK-1, a master regulator of bone remodelling, by fibroblast-like synoviocytes (2010) (3)
- Modulating Target Protein Biology Through the Re-mapping of Conformational Distributions Using Small Molecules (2021) (3)
- Identification of synovial biomarkers of response to treatment in spondyloarthropathy (2005) (3)
- Overexpression of Transmembrane TNF Drives Development of Ectopic Lymphoid Structures in the Bone Marrow and B Cell Lineage Alterations in Experimental Spondyloarthritis (2021) (2)
- 75 – Ankylosing Spondylitis (2013) (2)
- OR6-004 – MRP8/14 promote MSU-crystal induced inflammation (2013) (2)
- SAT0284 An add-on training program involving breathing exercises, cold exposure, and meditation attenuates inflammation and disease activity in axial spondyloarthritis (2018) (2)
- Comment on: ‘Spondyloarthritis: may the force be with you?’, the Editorial by McGonagle et al (2014) (2)
- Mechanisms and clinical relevance of TRAIL-triggered responses in synovial fibroblasts of rheumatoid arthritis patients (2011) (2)
- A1.20 HDAC5 regulates CXCL chemokine expression in RA FLS via the transcription factor IRF1 (2014) (2)
- Improvement in Signs and Symptoms of Active Ankylosing Spondylitis Following Treatment with Anti-Interleukin (IL)-17A Monoclonal Antibody Secukinumab Are Paralleled by Reductions in Acute Phase Markers and Inflammatory Markers S100A8 and A9 (Calgranulin A and B) (2012) (2)
- Response to: ‘Paying attention to enthesitis in early untreated arthritis: MRI for the evaluation of enthesitis’, by Zhou et al (2014) (2)
- P080 C-reactive protein: not only a marker, but also a cause of inflammation through metabolic reprogramming of human macrophages (2018) (2)
- Data showing non-conventional HLA-B27 expression in axial joints and gut tissue from B27 transgenic rats, and in frozen and paraffin-fixed synovial SpA tissue (2016) (2)
- 215. Sustained Clinical Remission in Patients with Non-Radiographic Axial Spondyloarthritis after Two Years of Adalimumab Treatment (2014) (2)
- Constitutive co-stimulation by B cells is sufficient to trigger T cell-driven autoimmune disease (2010) (2)
- Anti-citrullinated protein antibody response after primary EBV infection in kidney transplant patients (2018) (2)
- Paradoxical Augmentation of Experimental Spondyloarthritis by RORC Inhibition in HLA-B27 Transgenic Rats (2021) (2)
- A functional variant of TIR-domain-containing adaptor protein (TIRAP) is not associated with spondyloarthritis (2008) (2)
- Sustained remission with methotrexate monotherapy after 22-week induction treatment with TNF-alpha inhibitor and methotrexate in early psoriatic arthritis: an open-label extension of a randomized placebo-controlled trial (2019) (2)
- T.21. TNF Alpha Blockade Impairs T Cell Dependent Antibody Responses (2009) (2)
- Insulin-Like Growth Factor I Does Not Drive New Bone Formation in Experimental Arthritis (2016) (2)
- FRI0162 The link between angiogenesis and osteogenesis in spondyloarthritis (2018) (1)
- The rheumatoid arthritis synovial microenvironment promotes differentiation of monocytes into pro-angiogenic macrophages responsive to angiopoietin signaling (2012) (1)
- Reviewers for the Journal, January-June 2016. (2016) (1)
- OP0231 DUAL NEUTRALISATION OF IL-17A AND IL-17F WITH BIMEKIZUMAB WAS ASSOCIATED WITH IMPROVEMENTS IN PATIENT-REPORTED AND QUALITY-OF-LIFE OUTCOMES IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: RESULTS FROM A PHASE 2B, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RANGING STUDY (2019) (1)
- The presentation of the immunodominant epitope of HC gp-39 in the context of the RA-associated HLA class II molecules is specific for RA synovium (2002) (1)
- FRI0164 Innate Immune Stimulation Triggers Altered IL-1A/B Gene Expression and Experimental Spondyloarthritis in Hla-B27/Huβ2M Transgenic Rats (2014) (1)
- The TNF-ligand APRIL can control CIA by regulating antibody-production and stimulating anti-inflammatory IL-10 producing B cells (2011) (1)
- THU0517 Tie2 Signaling Induces A Pro-Inflammatory Phenotype in Rheumatoid Arthritis and Psoriatic Arthritis Macrophages (2014) (1)
- A2.13 Phenotypic and Molecular Profile of Innate Lymphoid Cells in Chronic Synovial Inflammation (2013) (1)
- need to go? how far have we come? how much further do we Standardisation of synovial tissue infiltrate analysis: (2006) (1)
- Commonly Occurs during Synovitides Specific for Rheumatoid Arthritis but Fibrin Deimination in Synovial Tissue Is Not (2005) (1)
- The diagnostic value of synovial histopathology in undifferentiated inflammatory arthritis: a prospective study in 154 consecutive patients (2003) (1)
- Synovial T/B cell lymphoid aggregates regulate the production of rheumatoid arthritis-specific autoantibodies (2007) (1)
- 115 – Etiology, pathogenesis, and pathophysiology of ankylosing spondylitis (2015) (1)
- THU0240 Early Clinical Response is a Better Predictor of Long-Term Remission than Baseline Disease Characteristics Following Adalimumab Treatment in Peripheral Spondyloarthritis (2015) (1)
- Etiology, pathogenesis, and pathophysiology of ankylosing spondylitis (2011) (1)
- OP0109 Sustained Clinical Remission in Patients with Non-Radiographic Axial Spondyloarthritis after Two Years of Adalimumab Treatment (2013) (1)
- WHAT HAVE WE LEARNED ABOUT NON-CLASSICAL FORMS OF HLA-B27 AND ITS ROLE IN THE PATHOGENESIS OF SPONDYLOARTHROPATHIES? (2014) (1)
- Relative overexpression of membrane-bound versus soluble TNF in spondyloarthritis (2012) (1)
- AB0021 In Psoriatic Arthritis Synovial Tissue Harbors Expanded T-Cell Clones Which Are not Fully Represented in Synovial Fluid or Blood Samples (2014) (1)
- Increasing B1a lymphocytes through APRIL overexpression in apolipoprotein E-deficient mice stabilizes advanced atherosclerotic lesions by decreasing necrotic area and increasing smooth muscle cell content (2016) (1)
- CHRONIC REJECTION OF HUMAN KIDNEY TRANSPLANTS IS CHARACTERIZED BY SPECIFIC PHENOTYPIC AND GENE EXPRESSION ALTERATIONS IN THE CD8+ LYMPHOCYTE SUBSET. (2004) (1)
- Short and long term synovial immunumodulation by etanercept in spondyloarthropathy (2005) (1)
- TRIBBLES HOMOLOG 1, A PERIPHERAL BLOOD MARKER OF CHRONIC REJECTION IN CLINICAL RENAL ALLOTRANSPLANTATION IDENTIFIED BY TRANSCRIPTOME PROFILING: ROLE AND CORRELATION WITH RENAL HISTOLOGY AND FUNCTION. (2006) (1)
- PERIPHERAL BLOOD GENE EXPRESSION OF CHRONIC REJECTION IN RENAL ALLOGRAFT TRANSPLANTATION. (2006) (1)
- SP0006 The IL-17 Pathway in The Pathogenesis of SPA: Focus on Structural Damage (2016) (1)
- OP0302 MUCOSAL-ASSOCIATED INVARIANT T (MAIT)-CELL-DERIVED IL-17A AND IL-17F PRODUCTION IS IL-23-INDEPENDENT AND BIASED TOWARDS IL-17F (2019) (1)
- Effective immunomodulation of peripheral joint pathology in spondyloarthropathy by etanercept (2005) (1)
- FRI0459 Hla-b27 positive versus hla-b27 negative spondyloarthritis: different phenotypes but similar disease burden (2013) (1)
- IL-17A producing mast cells as therapeutic target in spondyloarthritis (2010) (1)
- FRI0367 INFLAMMATORY PROCESSES IN EXPERIMENTAL SPONDYLOARTHRITIS ARE ACCOMPANIED BY FORMATION OF ECTOPIC LYMPHOID STRUCTURES IN THE BONE MARROW AND ALTERATIONS IN THE B CELL LINEAGE (2019) (1)
- 08.22 The role of transmembrane rather than soluble tnf in spondyloarthritis (2017) (1)
- In-reactor digestion of solid wastes (1992) (1)
- APRIL-mediated anti-inflammatory response of astrocytes in multiple sclerosis (2019) (1)
- Sa.18. The Type I IFN Signature Determines the Sustained Anti-citrullinated Protein Antibody Levels During TNFα Blockade in Rheumatoid Arthritis (2008) (0)
- Antibodies Using Complex-Specific Monoclonal Synovia of Rheumatoid Arthritis Patients Cartilage Glycoprotein-39 Complexes in Localization of MHC Class II / Human (2003) (0)
- IL-17 producing mast cells contribute to synovial inflammation in non-psoriatic and psoriatic spondyloarthritis (2010) (0)
- HLA-C*07 in axial spondyloarthritis: data from the German Spondyloarthritis Inception Cohort and the Spondyloarthritis Caught Early cohort (2019) (0)
- Molecular mechanisms of disease: osteoarthritisI68. Osteoarthritis (2012) (0)
- Effects of anti-tumor necrosis factor alpha on synovium in patients with spondylarthropathy: Comment on the article by Baeten et al - Reply. (2001) (0)
- 426 Dual interleukin-17A and interleukin-17F neutralisation with bimekizumab provides evidence for interleukin-17F contribution to immune-mediated inflammatory skin response (2017) (0)
- The effects of endoplasmatic reticulum stress on macrophage polarization and cytokine production: relevance for HLA-B27+ spondyloarthritis (2012) (0)
- Bone marrow edema in the sacroiliac joint-degenerative sacroiliac joint disease might be more likely than spondyloarthritis: comment on the article by Turina et al Reply (2017) (0)
- FRI0034 Suppression of hdac5 expression by inflammatory cytokines is required to promote cxcl chemokine production in ra fls (2013) (0)
- Decreased Soluble TNF-α in Spondyloarthritis Versus Rheumatoid Arthritis Synovitis (2010) (0)
- Flow cytometric determination of cytokine profile of peripheral blood and mucosal T lymphocytes in patients with fistulizing and non-fistulizing Crohn's disease (2000) (0)
- Interleukin 33 expression in human arthritis (2011) (0)
- THU0367 Fast Relapse Upon Discontinuation of Tumor Necrosis Factor Blocking Therapy in Patients with Peripheral Spondyloarthritis (2013) (0)
- FRI0128 Utility of Enthesitis Assessments in Peripheral Spondyloarthritis – Data from the Ability-2 Trial (2014) (0)
- OP0107 Ectopic Lymphoid Neogenesis is Specifically Associated with Activation of the IL-23/IL-17 Pathway in Rheumatoid Synovitis (2014) (0)
- FRI0136 TNF-Inhibitors and its Effect on Disease Course and Pregnancy Outcome in RA and SPA Patients (2015) (0)
- IL-17 INHIBITION : EMERGING PERSPECTIVES IN THE FUTURE MANAGEMENT OF AXIAL SPONDYLOARTHRITIS (2015) (0)
- Growth promoting effect of human cartilage glycoprotein-39 (HC gp-39)on synovial fibroblasts. (2005) (0)
- AB0895 Serum biomarkers to predict clinical response in proof-of-concept trials in spondyloarthritis (2013) (0)
- Isolation of colonie mucosal lamina propria and intra-epithelial lymphocytes: mechanical versus enzymatic isolation (1998) (0)
- FRI0006 Class 3 Semaphorins Modulate The Invasive Capacity of Rheumatoid Arthritis Fibroblast-like Synoviocytes (2016) (0)
- Inflammation and autoimmune responses are independent of peripheral MHC class II expression driven by CIITA pIV in collagen induced arthritis (2011) (0)
- T.10. The Cartilage-specific Molecule, Melanoma Inhibitory Activity, Contributes to Collagen-induced Arthritis (2009) (0)
- Serum biomarkers to predict clinical response in proof-of-concept trials in spondyloarthritis (2011) (0)
- The role of Bob1 in rheumatoid arthritis: potential implications for autoimmunity (2012) (0)
- THU0091 Tie2 induces an inflammatory phenotype in rheumatoid arthritis and psoriatic arthritis patients driven by angiopoietin-2 (2018) (0)
- Anti-TNFalpha induced apoptosis contributes to the induction of autoantibodies but not the decrease of synovial inflammation in spondyloarthropathy (2006) (0)
- Increased Type H Blood Vessels Precedes Pathological Osteogenesis And Inflammation In Experimental Spondyloarthritis. (2023) (0)
- OP0262 Is enthesitis the primary immunopathological lesion in HLA-B27-associated experimental and human spondyloarthritis? (2013) (0)
- Editor's acknowledgement (2005) (0)
- P093 Distinct and overlapping activities of IL-17A and TNF on the expression of proinflammatory cytokines and MMPS in psoriatic arthritis: rationale for ANTI-IL-17A/ANTI-TNFALPHA combination therapy? (2018) (0)
- SAT0309 CLINICAL, IMAGING AND BIOLOGIC FEATURES OF SPONDYLOARTHRITIS IN AN AT-RISK POPULATION: DATA FROM THE PRE-SPA COHORT (2019) (0)
- Serum MRP 8/14 is an inflammatory marker for chronic arthritis, partially originating from the inflamed joint (2003) (0)
- OP0239 Phenotypic and Molecular Profile of Innate Lymphoid Cells in Chronic Synovial Inflammation (2013) (0)
- [Off-label use of biologics for rare immunological disorders]. (2013) (0)
- SAT0012 C-reactive protein: not only a marker, but also a cause of inflammation through metabolic reprogramming of human macrophages (2018) (0)
- Chapter 6 Bone formation in Ankylosing Spondylitis during anti-tumor necrosis factor therapy imaged by [ 18 F ] Fluoride positron emission tomography (2018) (0)
- Interleukin-33 expression in human arthritis (2011) (0)
- Crohn's disease and ulcerative colitis show different distribution patterns of CD83 positive dendritic cells (1999) (0)
- SAT0251 Endoplasmic reticulum stress is not driving the altered cytokine production by macrophages in HLA-B27+ spondyloarthritis (2013) (0)
- Cross-Talk TLR − RI α Kupffer Cells through Fc Human Macrophages , Monocytes , and Proinflammatory Cytokine Production by Serum IgA Immune Complexes Promote (2017) (0)
- ShRNA-mediated knockdown of interleukin-6 expression rescues tumor necrosis factor α-inhibited osteogenesis in mouse mesenchymal precursor cells (2015) (0)
- Long term IL-17A inhibition by secukinumab leads to reduced spinal inflammation and unchanged fatty lesions in patients with ankylosing spondylitis (2013) (0)
- Correction: HLA-C*07 in axial spondyloarthritis: data from the German Spondyloarthritis Inception Cohort and the Spondyloarthritis Caught Early cohort (2019) (0)
- Is enthesitis the primary immunopathological lesion in HLA-B27-associated experimental and human spondyloarthritis? (2012) (0)
- EARLY EFFECT OF SECUKINUMAB IN REDUCING SPINAL INFLAMMATION AS DETECTED BY MAGNETIC RESONANCE IMAGING IN PATIENTS WITH ANKYLOSING SPONDYLITIS (2012) (0)
- Infliximab in Ankylosing Spondylitis (2005) (0)
- Secukinumab for ankylosing spondylitis – Authors' reply (2014) (0)
- SAT0021 Innate lymphoid cells are not a main source of il-17a in the inflamed spondyloarthritis joint (2018) (0)
- OP0093 Relative overexpression of transmembrane versus soluble TNF in human and experimental spondyloarthritis (2013) (0)
- Decreased soluble tumour necrosis factor expression in spondylarthritis versus rheumatoid arthritis synovitis (2010) (0)
- Weight analysis of a topological map to determine parameter importance (2004) (0)
- A10.17 Interleukin-36α is Expressed by Synovial Plasma Cells and Induces Cytokine Production in Human Fibroblasts (2013) (0)
- A4.11 Baseline Elevated Serum Levels of Calprotectin as Independent Marker for Radiographic Spinal Progression in Ankylosing Spondylitis (2013) (0)
- The inflammatory function of human IgA (2018) (0)
- FRI0021 The rheumatoid arthritis synovial microenvironment promotes differentiation of monocytes into pro-angiogenic macrophages responsive to angiopoietin signaling (2013) (0)
- Relative increase of IL-10 producing peripheral blood T lymphocytes after anti-TNF-A chimeric antibody (infliximab) treatment in fistulizing Crohn's disease (2000) (0)
- FRI0150 Mtor blockade by rapamycin decreases arthritis and spondylitis development and severity in hla-b27 transgenic rats (2018) (0)
- Comment on: Residual disease activity in psoriatic arthritis: discordance between the rheumatologist's opinion and minimal disease activity measurement: reply. (2018) (0)
- OP0205 April induces a novel subset of iga+ regulatory b cells that suppress inflammation through the expression of il-10 and pd-l1 (2018) (0)
- Modulation of humoral immune responses as a novel mechanism of action of tumour necrosis factor blockade (2010) (0)
- A5.31 The Role of BOB1 in Rheumnatoid Arthritis: Potential Implications for Autoimmunity (2013) (0)
- Lymphoid Neogenesis Synovitis Is Independent of Ectopic B Lymphocyte Autoimmunity in Rheumatoid Verweij (2008) (0)
- OP0089 Genetic studies on DICKKOPF-1, sclerostin and the severity of joint destruction in rheumatoid arthritis (2013) (0)
- F.131. DKK-1, a Master Regulator of Bone Remodelling, is Abundantly Expressed in Peripheral Inflammatory Arthritis (2009) (0)
- OP0192 Sirtuin Deacetylase 2 Inhibition Suppresses Inflammatory Activation of Rheumatoid Arthritis Fibroblast-Like Synoviocytes and IFN-Γ–Differentiated Macrophages (2014) (0)
- P126/O29 mTOR blockade by rapamycin decreases arthritis and spondylitis development and severity in HLA-B27 transgenic rats (2019) (0)
- FRI0201 Healthy individuals at increased risk for axial spondyloarthritis would consider using medication in a preventive setting (2018) (0)
- The role of Bob1 in rheumatoid arthritis: potential implications for autoimmunity (2012) (0)
- OP0200 Circulating, Auto-Reactive B Cells Specific for Citrullinated Antigens in Patients with Rheumatoid Arthritis Display An Activated, Proliferative Phenotype (2016) (0)
- Distinct synovial immunopathology in juvenile onset spondyloarthritis and other forms of juvenile idiopathic arthritis. (2006) (0)
- Detection of Genuine Anti-citrullinated Protein Antibodies in Mice Reveals Their Presence in BALB/c but not DBA/1 and SJL Mice Hyperimmunized with Citrullinated Collagen (2010) (0)
- ER stress abrogates the immunosuppressive effect of IL-10 on human macrophages through inhibition of STAT3 activation (2019) (0)
- AB0069 TIE2 signalling induces a pro-inflammatory and pro-angiogenic phenotype in differentiated macrophages, independently of macrophage polarization conditions (2013) (0)
- OP0273 Transmembrane tnf signalling through tnf-ri induces spa-like inflammation, whereas signallingthrough tnf-rii is crucial for new bone formation (2018) (0)
- 064 Mucosal-associated invariant T (MAIT) cell-derived IL-17A and IL-17F production is IL-23-independent and biased towards IL-17F (2019) (0)
- Increased expression of E 7 integrin in uninflamed mucosa of patients with spondyloarthropathy (1998) (0)
- FcαRI co-stimulation converts human intestinal CD103+ dendritic cells into pro-inflammatory cells through glycolytic reprogramming (2018) (0)
- The Gut and Spondyloarthritis, Including Aspects of Inflammatory Bowel Disease (2006) (0)
- Response to: ’To DAPSA or not to DAPSA? That is not the question' by Schoels et al (2018) (0)
- Effects of chemical agents and enzymes on the detection of lymphocyte surface markers. (1998) (0)
- Relative overexpression of membrane-bound versus soluble TNF in spondyloarthritis (2012) (0)
- SAT0662 SERUM INFLAMMATORY ANGIOGENIC AND TISSUE REMODELING BIOMARKERS IN PERIPHERAL SPONDYLOARTHRITIS BEFORE AND AFTER IL-17A BLOCKADE (2019) (0)
- OP0254 Cytokine-Induced JNK-Dependent Downregulation of the Forkhead Box O Transcription Factor Foxo1 Promotes Survival and Proliferation of Fibroblast-Like Synoviocytes in Rheumatoid Arthritis (2013) (0)
- Local production of soluble CD163 in the spondyloarthropathic joint (2003) (0)
- [Inflammation and structural organ damage: chicken or egg?]. (2013) (0)
- Specific Phenotypical Markers for Human Polarized Macrophages (2010) (0)
- BSR AND BHPR ORAL PRESENTATION OF ABSTRACTS ORAL ABSTRACTS 1: SPONDYLOARTHROPATHIES (2012) (0)
- Mast cells contribute to synovial inflammation in non-psoriatic and psoriatic spondyloarthritis (2010) (0)
- Microarray data mining uncovers neurotrophins and their receptors as potential mediators in spondyloarthritis (SpA) (2003) (0)
- OR.42. Constitutive Expression of the Costimulatory Molecule CD70 by Non-antigen Specific B Cells is Sufficient to Drive T Cell-driven Autoimmune Disease (2009) (0)
- Myeloid-related protein (MRP) 8 and MRP 14 in rheumatoid arthritis and spondyloarthropathy (2003) (0)
- Bone formation in ankylosing spondylitis during anti-tumour necrosis factor therapy imaged by 18 F-fluoride positron emission tomography RHEUMATOLOGY (2018) (0)
- Chapter 20 – Synovial Immunopathology in Spondyloarthropathy (2007) (0)
- Innate Lymphoid Cells Type 2 Attenuate Inflammatory Arthritis and Protect from Bone Destruction (2018) (0)
- FRI0623 [18F]fluoride PET-CT imaging of bone formation in ankylosing spondylitis before and after 12 weeks of ANTI-TNF treatment (2017) (0)
- SAT0231 Baseline Elevated Serum Levels of Calprotectin as Independent Marker for Radiographic Spinal Progression in Ankylosing Spondylitis (2013) (0)
- Inflammatory bowel disease and subclinical gut inflammation in spondyloarthropathy patients are associated with increased expression of the E-cadherin/catenin complex (1999) (0)
- IgM anti-dsDNA antibodies are the main anti-nuclear reactivity induced by infliximab but not etanercept treatment: biological and clinical implications (2005) (0)
- Treat to target in PsA should focus on clinical measures. Response to: ‘DAPSA versus cDAPSA: do we need to use CRP?’ by Gonçalves et al (2019) (0)
- Effects of chemical agents and enzymes on lymphocyte surface markers (1999) (0)
- Beneficial effects of myeloid related S100 proteins in kidney transplantation (2014) (0)
- Juvenile chronic arthritis displays synovial features distinct from both spondyloarthropathy and rheumatoid arthritis (2005) (0)
- The use of neural network algorithms for the classification of undifferentiated arthritis by synovial histopathology (2003) (0)
- Monoclonal B Cell Expansion and Antigen-driven Somatic Hypermutation of Ig VH Genes in Synovial Membrane of Patients with Crystal-Induced Arthritis (129.3) (2007) (0)
- Microarrays uncover serum elisa levels of metalloproteinase-3 (MMP3) as a useful parameter to measure disease activity in anky-losing spondylitis (AS) (2003) (0)
- Effect of infliximab on matrix metalloprotelinase (MMP)-1,-2,-3 and tissue inhibitors of matrix metalloproteinases (TIMP)-1,-2 in spondyloarthropathy (SpA) synovitis (2003) (0)
- Correction: HLA-C*07 in axial spondyloarthritis: data from the German Spondyloarthritis Inception Cohort and the Spondyloarthritis Caught Early cohort (2019) (0)
- P100 The link between angiogenesis and osteogenesis in spondyloarthritis (2018) (0)
- Identification of distinct polarized macrophage subsets in inflammatory arthritis (2010) (0)
- Reply (2017) (0)
- Secreted melanoma inhibitory activity (MIA) is a biomarker of chondrocyte anabolism. (2006) (0)
- Tie2 signaling induces a pro-inflammatory and pro-chemotactic phenotype in differentiated macrophages, independently of macrophage polarization conditions (2013) (0)
- Building decision tree classifiers using a Kohonen self-organizing map (2004) (0)
- A proof-of-concept study with the tyrosine kinase inhibitor nilotinib in spondyloarthritis (2016) (0)
- SAT0342 Arthritis and Enthesitis Remission during Adalimumab Treatment in Peripheral Spondyloarthritis: Year-2 Results from Ability-2 (2014) (0)
- Oral abstracts 1: SpondyloarthropathiesO1. Detecting axial spondyloarthritis amongst primary care back pain referrals (2012) (0)
- HLA-C*07 in axial spondyloarthritis: data from the German Spondyloarthritis Inception Cohort and the Spondyloarthritis Caught Early cohort (2019) (0)
- Nucleosomes, but not type I interferons, contribute to the induction of anti-nuclear antibodies by TNF alpha blockade in spondyloarthritis (2008) (0)
- AB0114 IL12P40/IL23P40 BLOCKADE WITH USTEKINUMAB DECREASES THE INFLAMMATORY INFILTRATE AND MODULATES MOLECULAR PATHWAYS IN THE SYNOVIUM OF PSORIATIC ARTHRITIS PATIENTS (2020) (0)
- Different cytokine profiles in peripheral blood and mucosal T lymphocytes of normal controls, Crohn's disease and ulcerative colitis patients (2000) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Dominique L. P. Baeten?
Dominique L. P. Baeten is affiliated with the following schools:
